Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Oncology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molonc.2010.08.002PMID 20800559PMCID PMC3110681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

  2011cited by this paper
• Clinical Significance of Human Kallikrein7 Gene Expression in Colorectal Cancer

  2010cited by this paper
• Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.

  2010cited by this paper
• Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.

  2010cited by this paper
• Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs

  2010cited by this paper
• Fluorescence in situ Hybridization (FISH)

  2010cited by this paper
• Recurrent RECQL4 imbalance and increased gene expression levels are associated with structural chromosomal instability in sporadic osteosarcoma.

  2009cited by this paper
• Cancer-causing karyotypes: chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function.

  2009cited by this paper
• KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma

  2009cited by this paper
• Diverse molecular pathways in ovarian cancer and their clinical significance.

  2009cited by this paper
• The biology of ovarian cancer: new opportunities for translation

  2009cited by this paper
• Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map

  2009cited by this paper
• Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity.

  2009cited by this paper
• Chromosomal instability determines taxane response

  2009cited by this paper
• A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.

  2009cited by this paper
• Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

  2009cited by this paper
• Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance

  2009cited by this paper
• High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis

  2009cited by this paper
• Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer

  2009influential reference
• Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.

  2009cited by this paper
• Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies

  2009cited by this paper
• Large‐scale genomic analysis of ovarian carcinomas

  2009cited by this paper
• The impact of p53 and p73 on aneuploidy and cancer.

  2008cited by this paper
• Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.

  2008cited by this paper
• Kallikreins as microRNA targets: an in silico and experimental-based analysis

  2008cited by this paper
• MicroRNA Expression Profiles in Serous Ovarian Carcinoma

  2008cited by this paper
• Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

  2008cited by this paper
• Prostate-specific antigen and prostate cancer: prediction, detection and monitoring

  2008cited by this paper
• Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer

  2008cited by this paper
• Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines

  2008cited by this paper
• Identification and analysis of mammalian KLK6 orthologue genes for prediction of physiological substrates

  2008cited by this paper
• Fluorescence In Situ Hybridization

  2008cited by this paper
• Prognostic value of kallikrein‐related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA)

  2008cited by this paper
• Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

  2008cited by this paper
• Chromosomal abnormalities in cancer.

  2008cited by this paper
• Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells

  2007cited by this paper
• High-Resolution Single Nucleotide Polymorphism Array Analysis of Epithelial Ovarian Cancer Reveals Numerous Microdeletions and Amplifications

  2007cited by this paper
• Genomic mechanisms and measurement of structural and numerical instability in cancer cells.

  2007cited by this paper
• The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

  2007cited by this paper
• Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer

  2007cited by this paper
• Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects

  2007influential reference
• MicroRNAs and cancer: Profile, profile, profile

  2007cited by this paper
• Amplicon profiles in ovarian serous carcinomas

  2007cited by this paper
• Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

  2006cited by this paper
• Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer

  2006cited by this paper
• microRNAs exhibit high frequency genomic alterations in human cancer.

  2006cited by this paper
• Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.

  2006cited by this paper
• Cellular distribution of human tissue kallikreins: immunohistochemical localization

  2006cited by this paper
• Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer

  2006cited by this paper
• Centrosome amplification, chromosome instability and cancer development.

  2005cited by this paper
• Downregulation of Human Kallikrein 10 (KLK10/NES1) by CpG Island Hypermethylation in Breast, Ovarian and Prostate Cancers

  2005cited by this paper
• KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.

  2005cited by this paper
• Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer.

  2005cited by this paper
• Fluorescence In Situ Hybridization (FISH)

  2004cited by this paper
• The emerging roles of human tissue kallikreins in cancer

  2004cited by this paper
• The DNA sequence and biology of human chromosome 19

  2004cited by this paper
• Characterisation of human kallikrein 6/protease M expression in ovarian cancer

  2004cited by this paper
• Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

  2004cited by this paper
• Preparation of Cytogenetic Specimens from Tissue Samples

  2004cited by this paper
• P53 Expression, Dna Ploidy and Mitotic Index as Prognostic Factors in Patients with Epithelial Ovarian Carcinoma

  2004cited by this paper
• Multi-color FISH techniques.

  2004cited by this paper
• Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.

  2003cited by this paper
• Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas

  2003cited by this paper
• Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.

  2003cited by this paper
• Chromosomal instability in osteosarcoma and its association with centrosome abnormalities.

  2003cited by this paper
• Parallel overexpression of seven kallikrein genes in ovarian cancer.

  2003cited by this paper
• Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.

  2002cited by this paper
• Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

  2002cited by this paper
• Multicolor spectral karyotyping of serous ovarian adenocarcinoma

  2002cited by this paper
• The Spectrum of Human Kallikrein 6 (Zyme/Protease M/Neurosin) Expression in Human Tissues as Assessed by Immunohistochemistry

  2001cited by this paper
• Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.

  2001cited by this paper
• Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

  2001cited by this paper
• Genetic analysis of early- versus late-stage ovarian tumors.

  2001cited by this paper
• Nonrandom chromosomal imbalances in human ovarian surface epithelial cells immortalized by HPV16-E6E7 viral oncogenes.

  2001cited by this paper
• Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis

  2000cited by this paper
• Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications.

  2000cited by this paper
• Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas

  2000cited by this paper
• Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.

  2000cited by this paper
• Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases

  1999cited by this paper
• Chromosome abnormalities in ovarian adenocarcinoma: II. prognostic impact of nonrandom chromosome abnormalities in 244 cases

  1999influential reference
• p53 MUTATION, ALLELE LOSS ON CHROMOSOME 17p, AND DNA CONTENT IN OVARIAN CARCINOMA

  1996cited by this paper
• Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies.

  1996cited by this paper
• Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

  1995cited by this paper
• Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma

  1994cited by this paper
• Clonal chromosome abnormalities in 54 cases of ovarian carcinoma.

  1994cited by this paper
• An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

  1992influential reference
• Chromosome aberrations in 35 primary ovarian carcinomas

  1992cited by this paper
• Chromosome aberrations in 60 primary ovarian carcinomas

  1992cited by this paper
• Prognostic impact of chromosome aberrations in ovarian cancer.

  1992cited by this paper
• Epithelial carcinoma of the ovary:prognostic importance of histologic grade.

  1975cited by this paper
• Epithelial carcinoma of the ovary:prognostic importance of histologic grade.

  1975cited by this paper
• STATISTICAL METHODS

  1967cited by this paper

• Differential regulation of mesoscale chromosome conformations in osteoblasts and osteosarcoma

  2025cites this paper
• Differential Regulation of Large-scale Chromosome Conformations in Osteoblasts and Osteosarcoma

  2024cites this paper
• Epigenetic regulation in ovarian cancer.

  2024cites this paper
• Effect of oocyte vitrification on DNA damage in metaphase II oocytes and the resulting preimplantation embryos

  2019cites this paper
• Profiling copy number alterations in cell-free tumour DNA using a single-reference

  2018cites this paper
• Current Opinion in Gynecology and Obstetrics Evidence for Predictive Markers of Platinum Effectiveness in Ovarian Carcinoma by Microarray-based Comparative Genomic Hybridization

  2018cites this paper
• Molecular Biomarkers in Ovarian Carcinoma

  2017cites this paper
• Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation

  2017cites this paper
• Molecular Profiling and Significance of Circulating Tumor Cell Based Genetic Signatures.

  2017cites this paper
• A computational analysis of the genetic and transcript diversity at the kallikrein locus

  2016cites this paper
• Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy

  2016cites this paper
• Identification of genomic signatures in circulating tumor cells from breast cancer

  2015cites this paper
• 10 Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients

  2015cites this paper
• Prognostic significance of multiple kallikreins in high-grade astrocytoma

  2015cites this paper
• Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients

  2015cites this paper
• Epigenetic Analysis of the Kallikrein Gene Family and Associated Pathways as a Novel Panel of Prostate Cancer Biomarkers

  2015cites this paper
• Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer

  2015cites this paper
• Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers

  2014cites this paper
• The Impact of Chromosomal Aberrations on the Regulation of Kallikrein 6 Expression in Serous Ovarian Carcinoma

  2013influential citation
• Sarcomas More Common in Children

  2013cites this paper
• Characterization of Kallikrein 6 N-glycosylation Patterns and Identification of Sialylated Glycoproteins in Ovarian Cancer

  2013cites this paper
• Kallikrein-related Peptidase 6

  2013cites this paper
• Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.

  2013cites this paper
• Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

  2013cites this paper
• The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)

  2012cites this paper
• Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients

  2012cites this paper
• Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers

  2012cites this paper
• Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer

  2012cites this paper
• Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance

  2012influential citation
• Identification and validation of Kallikrein‐ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry

  2011cites this paper
• Genomic instability and copy‐number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas

  2011cites this paper